Truelixir Life Science Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 15-11-2024
- Paid Up Capital ₹ 0.10 M
as on 15-11-2024
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 25.88 Cr
as on 15-11-2024
- Revenue 49.38%
(FY 2023)
- Profit 35.25%
(FY 2023)
- Ebitda 353.78%
(FY 2023)
- Net Worth -34.71%
(FY 2023)
- Total Assets -6.39%
(FY 2023)
About Truelixir Life Science
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹25.88 Cr.
Ashok Bedse, Sunanda Bedse, Nilesh Patil, and Two other members serve as directors at the Company.
- CIN/LLPIN
U74999MH2018PTC308831
- Company No.
308831
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 May 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Aurangabad, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Truelixir Life Science?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Bedse  | Director | 02-May-2018 | Current |
| Sunanda Bedse | Director | 29-Apr-2019 | Current |
| Nilesh Patil | Director | 02-May-2018 | Current |
| Kailash Borade | Director | 02-May-2018 | Current |
| Harsh Tanpure | Director | 26-Mar-2022 | Current |
Financial Performance of Truelixir Life Science.
Truelixir Life Science Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 49.38% increase. The company also saw a substantial improvement in profitability, with a 35.25% increase in profit. The company's net worth observed a substantial decline by a decrease of 34.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Truelixir Life Science?
In 2023, Truelixir Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bedse Pulp Conversion Industries Pvt LtdActive 36 years 2 monthsAshok Bedse, Sunanda Bedse and 1 more are mutual person
- Govind Ganga Farmers Producer Company LimitedActive 3 years 2 months
Kailash Borade is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 06 Apr 2024 | ₹4.00 M | Open |
Others Creation Date: 28 Dec 2022 | ₹2.50 Cr | Open |
Others Creation Date: 30 Dec 2020 | ₹3.00 Cr | Open |
How Many Employees Work at Truelixir Life Science?
Truelixir Life Science has a workforce of 60 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Truelixir Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Truelixir Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
